Paraganglioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Prognostic's Factors of Head and Neck Paragangliomas Evolution
Condition:   Paraganglioma Intervention:   Other: Characterization of a population with cervical paragangliomas Sponsor:   Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2022 Category: Research Source Type: clinical trials

A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial
Condition:   Advanced or Metastatic Paraganglioma/ Pheochromocytoma Intervention:   Drug: Anlotinib Sponsor:   Nanjing First Hospital, Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2021 Category: Research Source Type: clinical trials